BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc.: Clinical stage company utilizing AI technology platform to identify improved therapies in neuroscience and immuno-oncology. BXCL501 (sublingual dexmedetomidine): Met primary, key secondary and exploratory endpoints in two pivotal Phase 3 trials for the acute treatment of agitation in patients with schizophrenia (SERENITY I) and bipolar disorder (SERENITY II). NDA submission to FDA planned 1Q21; Phase 1b/2 trial (TRANQUILITY) ongoing for the acute treatment of agitation associated with geriatric dementia. Data expected 4Q20; BXCL701 (innate immunity activator): Phase 1b/2 ongoing of BXCL701 and KEYTRUDA for Prostate Cancer (tNEPC).
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - New England
Clinical Stage
Phase III, Phase l or ll
Disease Space
Central Nervous System, Oncology
Industry
Biotechnology
Listing
Public, USA
Market Cap
1B +
Therapeutic Modalities
Platform Technology, Small Molecule
Website:
Address:
555 Long Wharf Drive
5th Floor
New Haven, CT 06511
United States

Company Participants at Solebury Trout Corporate Access 1x1 Calls - Week of April 13

  • Vimal Mehta, Dr, CEO

Top 10 Holders of BioXcel Therapeutics, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Fidelity Management & Research Co. LLC 10.65 1,919,986 101.01 13F 9/30/20
State Street Corp. 7.17 1,293,856 68.07 13F 9/30/20
Artemis Investment Management LLP 5.55 1,001,708 52.70 13F 9/30/20
DNCA Finance SA 3.66 892,453 46.95 Stakes 3/3/20
Vanguard Group, Inc. (Subfiler) 4.60 829,760 43.65 13F 9/30/20
The Vanguard Group, Inc. 4.15 753,588 39.65 Funds 11/30/20
Citadel LP 4.16 749,621 39.44 13F 9/30/20
Victory Capital Management, Inc. (Investment Management) 3.30 594,294 31.27 13F 9/30/20
AllianceBernstein LP 3.27 590,285 31.05 13F 9/30/20
Logos Global Management LP 3.05 550,000 28.94 13F 9/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.